Low dimensionality of phenotypic space as an emergent property of coordinated teams in biological regulatory networks
暂无分享,去创建一个
H. Levine | M. Jolly | K. Hari | Pradyumna Harlapur | Aashna Saxena | Aishwarya Girish | Kushal Haldar | Tanisha Malpani
[1] D. Kessler,et al. Minimal frustration underlies the usefulness of incomplete regulatory network models in biology , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Onuchic,et al. Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer , 2022, bioRxiv.
[3] V. Rajapakse,et al. Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models , 2022, Nature Communications.
[4] M. Jolly,et al. Emergence of hybrid states of stem-like cancer cells correlates with poor prognosis in oral cancer , 2022, iScience.
[5] S. Quake. The Tabula Sapiens: a multiple organ single cell transcriptomic atlas of humans , 2021, bioRxiv.
[6] M. Jolly,et al. Landscape of epithelial–mesenchymal plasticity as an emergent property of coordinated teams in regulatory networks , 2021, bioRxiv.
[7] M. Jolly,et al. Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes , 2021, Physical biology.
[8] M. Jolly,et al. A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells , 2021, bioRxiv.
[9] M. Jolly,et al. Systems-level network modeling deciphers the master regulators of phenotypic plasticity and heterogeneity in melanoma , 2021, bioRxiv.
[10] M. Jolly,et al. Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer , 2020, bioRxiv.
[11] M. Jolly,et al. Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology , 2020, bioRxiv.
[12] C. Kadelka,et al. A meta-analysis of Boolean network models reveals design principles of gene regulatory networks , 2020, Science advances.
[13] Atchuta Srinivas Duddu,et al. Multi-stability in cellular differentiation enabled by a network of three mutually repressing master regulators , 2020, Journal of the Royal Society Interface.
[14] Shubham Tripathi,et al. Biological Networks Regulating Cell Fate Choice Are Minimally Frustrated. , 2020, Physical review letters.
[15] K. Dill,et al. How Do Cells Adapt? Stories Told in Landscapes. , 2020, Annual review of chemical and biomolecular engineering.
[16] M. Jolly,et al. Cancer Stem Cell Plasticity – A Deadly Deal , 2019, Frontiers in Molecular Biosciences.
[17] Shivashankar H. Nagaraj,et al. Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer , 2019, Journal of clinical medicine.
[18] Aaron M. Newman,et al. Single-cell transcriptional diversity is a hallmark of developmental potential , 2019, Science.
[19] J. Onuchic,et al. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways , 2019, Proceedings of the National Academy of Sciences.
[20] S. Hanash,et al. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas , 2019, Pharmacology & therapeutics.
[21] E. Furth,et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.
[22] S. Zapperi,et al. Topography of epithelial–mesenchymal plasticity , 2018, Proceedings of the National Academy of Sciences.
[23] T. Voet,et al. Identification of the tumour transition states occurring during EMT , 2018, Nature.
[24] H. Levine,et al. EMT and MET: necessary or permissive for metastasis? , 2017, bioRxiv.
[25] Bin Huang,et al. Interrogating the topological robustness of gene regulatory circuits by randomization , 2016, bioRxiv.
[26] I. Mackenzie,et al. Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma , 2016, EBioMedicine.
[27] Reka Albert,et al. Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes , 2015, npj Systems Biology and Applications.
[28] Luis Mendoza,et al. A Boolean network model of human gonadal sex determination , 2015, Theoretical Biology and Medical Modelling.
[29] Catherine Ha Ta,et al. An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States , 2015, PLoS Comput. Biol..
[30] Z. Bao,et al. The Regulatory Landscape of Lineage Differentiation in a Metazoan Embryo. , 2015, Developmental cell.
[31] Eshel Ben-Jacob,et al. MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.
[32] Richard C. McEachin,et al. Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer , 2013, PloS one.
[33] E. Levanon,et al. Human housekeeping genes, revisited. , 2013, Trends in genetics : TIG.
[34] Jianhua Xing,et al. Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. , 2013, Biophysical journal.
[35] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[36] Rui Chang,et al. Systematic Search for Recipes to Generate Induced Pluripotent Stem Cells , 2011, PLoS Comput. Biol..
[37] Sui Huang,et al. Understanding gene circuits at cell-fate branch points for rational cell reprogramming. , 2011, Trends in genetics : TIG.
[38] T. Enver,et al. Forcing cells to change lineages , 2009, Nature.
[39] Griffin M. Weber,et al. BioNumbers—the database of key numbers in molecular and cell biology , 2009, Nucleic Acids Res..
[40] B. Hall,et al. Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest , 2006, Biological reviews of the Cambridge Philosophical Society.
[41] David J. Wooten,et al. Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity. , 2017, Cancer research.